Abstract

Early detection of Alzheimer’s disease (AD) can bring benefits to the patient by giving them time to process and prepare for the development of the disease in the future. To detect the early stages of AD, patients can take brain imaging tests, auto-encoders, genetic tests, mental state tests, and cerebral spinal fluid tests. Through these tests, patients can determine their amyloid build-up levels, tau build-up levels, possible chromosomes related to AD, and mental health illnesses related to AD.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call